Nik Deogun, senior vice president and editor in chief at CNBC, sent out the following announcement on Thursday:
I am pleased to announce that Meg Tirrell will join CNBC as a general assignment reporter, effective April 7th. Meg’s primary focus will be covering the biotechnology and pharmaceutical beat and will appear on both CNBC’s Business Day programming and CNBC.com.
Meg comes to us from Bloomberg News, which she joined in 2007. At Bloomberg News, she led the coverage of the biotechnology industry and reported on big merger & acquisition stories, including Amylin Pharmaceuticals and Genzyme, proxy fights at Forest Labs and Vivus as well as important FDA decisions. She also contributed to Bloomberg Television and Bloomberg Businessweek.
Meg holds a master’s degree in journalism from Northwestern University and a bachelor’s degree in English and music from Wellesley College.
Please join me in welcoming Meg to CNBC.
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…
Wall Street Journal reporter Ben Eisen has signed a contract with Norton to write a book about…
Reuters has hired Pia Krishnakutty as a news producer. She has been at The Print as a…
View Comments
Wise move by CNBC. Meg is one of the smartest in the business!